Clinical trial
Comparison of Efficacy of Methotrexate vs Apremilast in Moderate to Severe Plaque Psoriasis
NCT07337434 is registered in ClinicalTrials.gov with Syeda Sana Zaman as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Efficacy of Methotrexate vs Apremilast in Moderate to Severe Plaque Psoriasis
- Lead sponsor
- Syeda Sana Zaman
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 25, 2025
- Completion date
- June 25, 2026
- Enrollment
- 106 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic plaque psoriasis